InsidersTradesSigma
Hansa Biopharma AB Stock: price and management transactions · Finland · FIN-FSA
Follow the Hansa Biopharma AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Hansa Biopharma AB has published 1 reports. Market capitalisation: €2.9bn. The latest transaction was filed on 10 November 2025 (Purchase). Among the most active insiders: Charles Ballantyne. The full history is accessible without an account.
1
Insider Decl.
0
Thresholds
€70,854
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Hansa Biopharma AB Strong Buy (bullish), based on 7 analysts. Average price target: SEK 75.00.
31Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 November 2025
Declarations1 total
●
Arbetstagarrepresentant i styrelsen eller arbetstagarsuppleant, Ekonomichef/finanschef/finansdirektörExecutives
25,000 shares@ €2.83410.0025% mcap100.0% of flowAktieFI:A003T468-1
Ideal exit: 4 Aug 2026 (T+270)
1 of 1 declaration